1.

Record Nr.

UNISA996391816803316

Autore

Knott Edward <1582-1656.>

Titolo

Christianity maintained. Or a discouery of sundry doctrines tending to the ouerthrovve of Christian religion: contayned in the answere to a booke entituled, mercy and truth, or, charity maintayned by Catholiques [[electronic resource]]

Pubbl/distr/stampa

[Saint-Omer, : English College Press], Permissu superiorum. 1638

Descrizione fisica

[8], 3-80 p

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Epistle dedicatory signed I.H. [i.e. Edward Knott, the name Matthew Wilson adopted in 1602 and kept for the rest of his life].

Printer and place of publication from STC.

A reply to: Chillingworth, William.  The religion of Protestants a safe way to salvation.

Errata on verso of K4, final leaf.

Formerly also STC 5149.

Identifed as STC 5149 on UMI microfilm, reel 1302.

Appears at reel 1053 #3 (British Library copy), and at reel 1302 #4 (University of Dublin, Trinity College Library copy).

Title page marked and stained; some print faded and show-through.

Reproductions of the originals in the British Library and the Trinity College, University of Dublin. Library.

Sommario/riassunto

eebo-0018



2.

Record Nr.

UNINA9910813272203321

Titolo

Development of vaccines : from discovery to clinical testing / / edited by Manmohan Singh, Indresh K. Srivastava

Pubbl/distr/stampa

Hoboken, N.J., : John Wiley & Sons, c2011

ISBN

9786613175656

9781283175654

1283175657

9781118023631

1118023633

9781118023648

1118023641

9781118023624

1118023625

Edizione

[1st ed.]

Descrizione fisica

1 online resource (478 p.)

Altri autori (Persone)

Manmohan Singh <1964 November 8->

SrivastaIndresh K

Disciplina

615/.372

Soggetti

Vaccines

Drug development

Drug stability

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references and index.

Nota di contenuto

Microbial vaccines design : the reverse vaccinology approach / Roberto Rosini, Michele A. Barocchi, Rino Rappuoli -- Design and development of recombinant vaccines with viral properties / Gerd Lipowsky, Martin F. Bachmann -- Tools for vaccine design : prediction and validation of highly immunogenic and conserved class II epitopes, and development of epitope-driven vaccines / Anne S. De Groot ... [et al.] -- Virus like-particle vaccines advantages and challenges / Ted M. Ross ... [et al.] -- Design platforms of nanocapsules for human therapeutics or vaccines / Masaaki Kawano ... [et al.] -- Designing immunogens for vaccine development in reference to HIV / Aemro Kassa ... [et al.] --

Expression and purification of recombinant proteins for vaccine



applications / Carlo Zambonelli, Deeann Martinez-Guzmann, and Indresh K. Srivastava -- DNA vaccines for infectious diesase / Samuel Stepenson, Manmohan Singh, Indresh K. Srivastava -- Developing stable cell lines for the production of vaccine antigens / Xiaotian Zhong ... [et al.] -- Spectroscopy of vaccines / C. Russell Middaugh, Sangeeta B. Joshi -- Biophysical characterization of protein antigens within vaccine formulations / Padima Malyala, Derek O'Hagan, Manmohan Singh -- Structural characteristics predict the stability of HIV / Zohar Biron ... [et al.] -- Selection of optimal adjuvants and product factors that affect vaccine immunogenicity / Wei Wang, Manmohan Singh -- Lyophilization and stabilization of vaccines / James Chesko ... [et al.] -- Effect of buffers and stabilizers on vaccine stability and efficacy / Shireesh P. Apte, Sydney Ugwu -- Selection of final product containers / Luis Baez, Adrian Distler -- From the lab to the clinic : filing a phase I IND for an investigational vaccine / Kenneth G. Surowitz.

Sommario/riassunto

Development of Vaccines: From Discovery to Clinical Testing outlines the critical steps, and analytical tools and techniques, needed to take a vaccine from discovery through a successful clinical trial. Contributions from leading experts in the critical areas of vaccine expression, purification, formulation, pre-clinical testing and regulatory submissions make this book an authoritative collection of issues, challenges and solutions for progressing a biologic drug formulation from its early stage of discovery into its final clinical testing. A section with details and real-life experien